NLS Pharma: Funding, Investors & Team (Sep 2026)
NLS Pharma is a company in the clinical stage of drug development that specializes in neurobehavioral and neurocognitive disorders and their pharmacognosia. By prioritizing the needs of patients, they enhance their chances of success, and their effective collaboration with various experts from industry and academia allows for a tailored and focused approach.
NLS Pharma has raised $27.9M across 6 funding rounds on record, the most recent an undisclosed round of $500k announced in Dec 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NLS Pharma Company Profile and Key Stats
Latest funding round on record: Dec 2024.
NLS Pharma Funding Rounds
NLS Pharma raised $4.4M in a Post-IPO Equity announced in Apr 2022.
6 months later, a Post-IPO Equity of $4.0M was announced in Oct 2022.
2 months later, an undisclosed round of $10.0M was announced in Dec 2022.
1.3 years later, an undisclosed round of $1.8M was announced in Mar 2024.
7 months later, an undisclosed round of $7.2M was announced in Oct 2024.
2 months later, an undisclosed round of $500k was announced in Dec 2024.
NLS Pharma Founders and Leadership Team
Contact details for the NLS Pharma team: 1 of 2 have an email address on file.
Start 14-day free trial →NLS Pharma Funding Compared to Other Biotechnology Startups
NLS Pharma's latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NLS Pharma in Biotechnology and Stans
Companies Similar to NLS Pharma
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
NLS Pharma Funding FAQs
What does NLS Pharma do?
NLS Pharma is a company in the clinical stage of drug development that specializes in neurobehavioral and neurocognitive disorders and their pharmacognosia. By prioritizing the needs of patients, they enhance their chances of success, and their effective collaboration with various experts from industry and academia allows for a tailored and focused approach.
How much funding has NLS Pharma raised?
NLS Pharma has raised $27.9M across 6 rounds on record. The most recent is an undisclosed round of $500k announced in Dec 2024.
When did NLS Pharma last raise funding?
NLS Pharma's most recent funding round on record is an undisclosed round of $500k, announced in Dec 2024.
Who founded NLS Pharma?
FundedIQ lists Eric Konofal (Founder) at NLS Pharma.
Who is the CEO of NLS Pharma?
Alex Zwyer is listed as CEO at NLS Pharma.
Where is NLS Pharma headquartered?
NLS Pharma is based in Stans, Nidwalden, Switzerland.
How many employees does NLS Pharma have?
NLS Pharma is in the 1-10 employee band.
How does NLS Pharma's funding compare to other Biotechnology startups?
NLS Pharma's latest round of $500k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's NLS Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NLS Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.